Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionOral analgesic
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationInsomnia
Indication DetailsTreat insomnia
Regulatory Designation
PartnerPurdue Pharma L.P.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today